4CPS-194 Clinical impact of genomic biomarkers predictors of response and the therapeutic strategy in patients with myelodysplastic syndrome associated with del(5q)
4CPS-194 Clinical impact of genomic biomarkers predictors of response and the therapeutic strategy in patients with myelodysplastic syndrome associated with del(5q)